KRAS oncogene in lung cancer: focus on molecularly driven clinical trials

Emmanuelle Kempf, Benoît Rousseau, Benjamin Besse, Luis Paz-Ares
European Respiratory Review 2016 25: 71-76; DOI: 10.1183/16000617.0071-2015

Article Information

vol. 25 no. 139 71-76
DOI 
https://doi.org/10.1183/16000617.0071-2015
PubMed 
26929424
Published By 
European Respiratory Society
Print ISSN 
0905-9180
Online ISSN 
1600-0617
History 
  • Received September 16, 2015
  • Accepted October 12, 2015
  • Published online February 29, 2016.
Copyright & Usage 
Copyright ©ERS 2016. ERR articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

Author Information

  1. Emmanuelle Kempf1,2⇑,
  2. Benoît Rousseau2,3,
  3. Benjamin Besse4,5 and
  4. Luis Paz-Ares1
  1. 1Dept of Medical Oncology, Virgen del Rocio Teaching Hospital, Instituto de Biomedicina de Sevilla - IBIS, Seville, Spain
  2. 2Dept of Medical Oncology, Pharmacology Unit, AP-HP, Henri Mondor Teaching Hospital, Créteil, France
  3. 3Université Paris-Est, VIC DHU, Inserm U 955, Team 18, UPEC, Créteil, France
  4. 4Dept of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France
  5. 5Paris-Sud University, Inserm U981, Paris, France
  1. Emmanuelle Kempf, Pharmacology Unit, Henri Mondor University Hospital, 51 Avenue du Maréchal de Lattre de Tassigny 94010 Créteil Cedex, France. E-mail: emma{at}kempf.pro
View Full Text

Article usage

Article usage: February 2016 to May 2023

AbstractFullPdf
Feb 2016021
Mar 201655600300
Apr 201625292168
May 201612362139
Jun 201616169148
Jul 201610162153
Aug 201617220138
Sep 2016291485126
Oct 201623479116
Nov 201623326102
Dec 201617238140
Jan 201713294112
Feb 201715237107
Mar 201710292112
Apr 2017824096
May 2017727084
Jun 2017422474
Jul 2017421949
Aug 2017422776
Sep 2017322790
Oct 20171322674
Nov 2017423972
Dec 2017519743
Jan 2018331652
Feb 2018618332
Mar 2018117132
Apr 2018222242
May 2018026132
Jun 2018033431
Jul 2018025432
Aug 2018023727
Sep 2018022819
Oct 2018037427
Nov 2018154624
Dec 2018025326
Jan 2019615427
Feb 2019210433
Mar 2019310030
Apr 201928228
May 201959033
Jun 2019110321
Jul 2019510222
Aug 201939139
Sep 20191213222
Oct 2019110014
Nov 201928417
Dec 2019116227
Jan 202046119
Feb 202037216
Mar 2020414930
Apr 2020016031
May 202088335
Jun 20201210333
Jul 202039925
Aug 202086213
Sep 2020315034
Oct 2020712522
Nov 2020513337
Dec 202049719
Jan 20211311937
Feb 2021149834
Mar 20212114762
Apr 2021613826
May 2021312124
Jun 202139927
Jul 2021210924
Aug 202179533
Sep 2021712236
Oct 2021318553
Nov 2021814246
Dec 2021520244
Jan 20221028142
Feb 20221020748
Mar 2022819736
Apr 2022814143
May 2022911730
Jun 202259242
Jul 20221711219
Aug 2022311321
Sep 202205821
Oct 202218329
Nov 202266833
Dec 202255421
Jan 2023110822
Feb 2023410822
Mar 2023011218
Apr 202334321
May 202343021

Altmetrics

Back to top
View this article with LENS
Email
Print
Citation Tools

KRAS oncogene in lung cancer: focus on molecularly driven clinical trials
Emmanuelle Kempf, Benoît Rousseau, Benjamin Besse, Luis Paz-Ares
European Respiratory Review Mar 2016, 25 (139) 71-76; DOI: 10.1183/16000617.0071-2015
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

Subjects